炎症因子及其抑制剂对脑缺血再灌注损伤作用的研究进展
任靓明 田红旗
北京协和医学院 中国医学科学院放射医学研究所 天津市放射医学与分子核医学重点实验室,天津 300192
Research progress of inflammatory factors and their inhibitors on cerebral ischemia-reperfusion injury
REN Jingming TIAN Hongqi
Institute of Radiation Medicine, Peking Union Medical College & Chinese Academy of Medical Sciences Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Tianjin 300192, China
摘要 脑缺血再灌注损伤(CIRI)是严重危害人类健康的复杂的病理生理过程,其中炎症反应是诱发CIRI的重要因素之一,大量炎症因子诱导神经元凋亡或坏死,并介导微血管功能障碍,继发脑出血或脑水肿,对机体造成不可逆的损伤。因此寻求针对CIRI的有效防护和治疗策略具有重要意义。本文介绍白细胞介素(IL)-1、肿瘤坏死因子-α和IL-6等炎症因子在CIRI过程中发挥的生理功能,列举近年将炎症因子作为靶点CIRI相关的药物和天然产物,为临床针对性地治疗CIRI提供依据。
关键词 :
脑缺血 ,
再灌注损伤 ,
细胞因子 ,
炎症因子抑制剂
Abstract :Cerebral ischemia-reperfusion injury (CIRI) is a complex pathophysiological process and seriously endanger human health, in which inflammatory reaction is one of the important factors to induce CIRI. A large number of inflammatory factors effect neuronal apoptosis or necrosis, mediate microvascular dysfunction, and lead to cerebral hemorrhage or cerebral edema, causing irreversible damage to the body. Therefore, it is of great significance to seek effective prevention and treatment strategies for CIRI. This review introduces the physiological functions of inflammatory factors such as interleukin (IL)-1, tumor necrosis factor α and IL-6 in the process of CIRI, and lists the drugs and natural extracts related to inflammatory factors in recent years, so as to provide evidence for the clinical treatment of CIRI.
Key words :
Brain ischemia
Reperfusion injury
Cytokines
Anti-Inflammatory agents
基金资助: 天津市科技计划项目(19YFZCSY00350、17ZXX YSY00090);中国医学科学院放射医学研究所协助开发(委托)基金项目(IRM-QT2020045)。
通讯作者:
田红旗(1967.8-),男,博士,研究员;研究方向:放射医学。
作者简介 : 任靓明(1996.10-),女,中国医学科学院北京协和医学院放射医学研究所2020级放射医学专业在读硕士研究生;研究方向:放射医学。
[1] Stephenson J,Nutma E,Valk P,et al. Inflammation in CNS neurodegenerative diseases [J]. Immunology,2018,154(2):204-219.
[2] Orsini F,Fumagalli S,Császár E,et al. Mannose-Binding Lectin Drives Platelet Inflammatory Phenotype and Vascular Damage After Cerebral Ischemia in Mice via IL(Interleukin)-1α [J]. Arterioscler Thromb Vasc Biol,2018, 38(11):2678-2690.
[3] 王锐,李焕英,王卫.白细胞介素1受体拮抗剂对大鼠局灶性脑缺血再灌注神经细胞凋亡的影响[J].实用医学杂志,2008,19:3316-3317.
[4] Wong R,Lénárt N,Hill L,et al. Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neurons[J]. Brain Behav Immun,2019,76:126-138.
[5] 李俊杰,蒋海燕,邵建林.脑缺血-再灌注损伤大鼠脑组织中TNF-α,IL-6和IL-1β的表达[J].昆明医科大学学报,2016,37(9):31-35.
[6] Buntinx M,Moreels M,Vandenabeele F,et al. Cytokine-induced cell death in human oligodendroglial cell lines:I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis [J]. J Neurosci Res,2004,76(6):834-845.
[7] Wan JJ,Wang PY,Zhang Y,et al. Role of acute-phase protein ORM in a mice model of ischemic stroke [J]. J Cell Physiol,2019,234(11):20533-20545.
[8] Puel A,Casanova JL. The nature of human IL-6 [J]. J Exp Med,2019,216(9):1969-1971.
[9] Jiang M,Wang H,Jin M,et al. Exosomes from MiR-30d-5p-ADSCs Reverse Acute Ischemic Stroke-Induced,Autophagy-Mediated Brain Injury by Promoting M2 Microglial/Macrophage Polarization [J]. Cell Physiol Biochem,2018,47(2):864-878.
[10] De Bilbao F,Arsenijevic D,Moll T,et al. In vivo over-expression of interleukin-10 increases resistance to focal brain ischemia in mice[J]. J Neurochem,2009,110(1):12-22.
[11] Georgakis MK,Gill D,Rannikm?覿e K,et al. Genetically Determined Levels of Circulating Cytokines and Risk of Stroke [J]. Circulation,2019,139(2):256-268.
[12] Hedtj?覿rn M,Leverin AL,Eriksson K,et al. Interleukin-18 involvement in hypoxic-ischemic brain injury[J]. J Neurosci,2002,22(14):5910-5919.
[13] Chen Z,Xiang Y,Bao B,et al. Simvastatin improves cerebrovascular injury caused by ischemia-reperfusion through NF-κB-mediated apoptosis via MyD88/TRIF signaling [J]. Mol Med Rep,2018,18(3):3177-3184.
[14] Lu D,Shen L,Mai H,et al. HMG-CoA Reductase Inhibitors Attenuate Neuronal Damage by Suppressing Oxygen Glucose Deprivation-Induced Activated Microglial Cells [J]. Neural Plast,2019,2019:1-15.
[15] 刘亚军,王旋,胡海,等.瑞舒伐他汀预处理对缺血再灌注大鼠大脑中动脉血管平滑肌细胞炎症因子的影响及其机制[J].解剖学报,2019,50(6):713-717.
[16] Wu XJ,Sun XH,Wang SW,et al. Mifepristone alleviates cerebral ischemia-reperfusion injury in rats by stimulating PPAR γ[J]. Eur Rev Med Pharmacol Sci,2018,22(17):5688-5696.
[17] 李万平,何小苏,陶磊,等.芬戈莫德对MCAO/R损伤模型大鼠的改善作用研究[J].中国药房,2019,30(6):752-757.
[18] Liu Y,Feng S,Subedi K,et al. Attenuation of Ischemic Stroke-Caused Brain Injury by a Monoamine Oxidase Inhibitor Involves Improved Proteostasis and Reduced Neuroinflammation [J]. Mol Neurobiol,2019,57(2):937-948.
[19] Zhu S,Zhang Z,Jia L Q,et al. Valproic acid attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-pyroptosis pathways[J]. Neurochem Int,2019,124:141-151.
[20] Wowro SJ,Tong G,Krech J,et al. Combined Cyclosporin A and Hypothermia Treatment Inhibits Activation of BV-2 Microglia but Induces an Inflammatory Response in an Ischemia/Reperfusion Hippocampal Slice Culture Model [J]. Front Cell Neurosci,2019,13:273.
[21] Ma C,Wang X,Xu T,et al. Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway[J]. BMC Complement Altern Med,2019,19(1):320.
[22] 靳晓飞,张彐宁,周晓红,等.黄芪甲苷对脑缺血再灌注大鼠炎症因子及超微结构的影响[J].中国比较医学杂志,2020,30(4):1-6.
[23] Zheng T,Jiang H,Jin R,et al. Ginsenoside Rg1 attenuates protein aggregation and inflammatory response following cerebral ischemia and reperfusion injury [J]. Eur J Pharmacol,2019,853:65-73.
[24] Liu A,Zhu W,Sun L,et al. Ginsenoside Rb1 administration attenuates focal cerebral ischemic reperfusion injury through inhibition of HMGB1 and inflammation signals [J]. Exp Ther Med,2018,16(4):3020-3026.
[25] Zhang R,Liu C,Li Y,et al. Tenacissoside H Promotes Neurological Recovery of Cerebral Ischemia-reperfusion Injury in Mice by Modulating Inflammation and Oxidative stress via TrkB Pathway[J]. Clin Exp Pharmacol Physiol,2020.
[26] Li S,Bian L,Fu X,et al. Gastrodin pretreatment alleviates rat brain injury caused by cerebral ischemic-reperfusion [J]. Brain Res,2019,1712:207-216.
[27] Zhou J,Wu N,Lin L. Curcumin Suppresses Apoptosis and Inflammation in Hypoxia/Reperfusion-Exposed Neurons via Wnt Signaling Pathway [J]. Med Sci Monit,2020, 26:e920445.
[28] Dou Z,Rong X,Zhao E,et al. Neuroprotection of Resveratrol Against Focal Cerebral Ischemia/Reperfusion Injury in Mice Through a Mechanism Targeting Gut-Brain Axis [J]. Cell Mol Neurobiol,2019,39(6):883-898.
[29] Wang X,Li X,Jingfen W,et al. Higenamine alleviates cerebral ischemia-reperfusion injury in rats[J]. Front Biosci (Landmark Ed),2019,24:859-869.
[30] Qiu Z,Wang K,Jiang C,et al. Trigonelline protects hippocampal neurons from oxygen-glucose deprivation-induced injury through activating the PI3K/Akt pathway [J]. Chem Biol Interact,2020,317:108946.
[1]
乔建新1 刘熙鹏1 刘明1 王静辉1 管超楠2. 加贝酯对脑缺血再灌注损伤大鼠的影响及机制研究 [J]. 中国医药导报, 2021, 18(8): 10-14.
[2]
谢秋芳 张意侗 梁贵廷 段俊红 魏萱 王娟 刘博 樊玉珠. 虫草补肾胶囊治疗气阴两虚型糖尿病肾病患者的效果 [J]. 中国医药导报, 2021, 18(8): 157-160.
[3]
刘建魁 王本孝 王俊珺. 急性前循环脑梗死rt-PA静脉溶栓患者TIBI分级和血管再通、神经功能及短期预后的关系 [J]. 中国医药导报, 2021, 18(5): 76-79.
[4]
张俊涛1* 岳辰2* 倘艳锋2 贾宇东2 刘又文2. 原位组织工程技术修复骨与软骨损伤的应用进展 [J]. 中国医药导报, 2021, 18(3): 39-42.
[5]
陈哲1 张灵1 刘洁1 张斌2 高炳华1. 原发免疫性血小板减少症患者外周血CD4+T淋巴细胞表面PD-1表达水平分析 [J]. 中国医药导报, 2021, 18(1): 92-95.
[6]
刘文芳1 赵子申2 张海祥2. 透明质酸修护生物膜联合氯雷他定片治疗特应性皮炎的临床效果 [J]. 中国医药导报, 2020, 17(8): 139-143.
[7]
王颖 周红群 殷梅 缪薇 朱榆红. 依达拉奉联合缺血后处理对大鼠脑缺血再灌注损伤的影响 [J]. 中国医药导报, 2020, 17(5): 13-17.
[8]
刘宏1,2 易娅静3 于颖3 代巧妹1 张雨薇1 杨婧1 张博4 仲丽丽5. 基于雌激素受体介导的神经营养因子通路探讨左归丸对脑缺血再灌注损伤的保护作用 [J]. 中国医药导报, 2020, 17(35): 27-33.
[9]
肖荣1 赵春一1 郑莉明2 杨玲玲2 李艳2. 补脾胃泻阴火升阳汤治疗脾虚胃热型失眠的临床效果 [J]. 中国医药导报, 2020, 17(33): 137-140.
[10]
李慧敏 向净匀 吴杰 王琰 周爽 史永恒 王川 王斌. 白三烯B4/白三烯B4受体通路在脑缺血损伤发生机制中的研究进展 [J]. 中国医药导报, 2020, 17(31): 50-53.
[11]
张林丽1 宋景贵2. CD4 T淋巴细胞在脑卒中后抑郁发病机制中的研究进展 [J]. 中国医药导报, 2020, 17(31): 62-65.
[12]
王凯1,2 雷露2 曹金一2 段佳林2 文爱东2 乔逸2 杨志福2. 中药红花和黄芪对脑缺血损伤保护作用的研究进展 [J]. 中国医药导报, 2020, 17(3): 22-25.
[13]
王琪1 李延2 李勇3 吴限4▲. 李延教授运用化瘀祛痰汤治疗顽固性失眠的效果及对血清细胞因子的影响 [J]. 中国医药导报, 2020, 17(3): 119-122.
[14]
马乐 席建元 鲍秋羽. 托里消毒饮联合象皮生肌膏治疗慢性皮肤溃疡的临床研究 [J]. 中国医药导报, 2020, 17(25): 145-148.
[15]
李锦梧1 胡珊2 刘雁云3 许海3. 替吉奥、顺铂联合多西他赛协同治疗宫颈癌的临床效果 [J]. 中国医药导报, 2020, 17(14): 94-97,117.